Term
| What are Beclomethasone's side effects? |
|
Definition
| Fungal infection in the mouth. Minimal systemic effects |
|
|
Term
| Beclomethasone's trade names |
|
Definition
|
|
Term
| Beclomethasone's classification |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
|
Definition
| MDI .252 mg (0.084 mg/actuation) |
|
|
Term
| Beclomethasone's instruction |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| Beclomthasone dipropionate's classification |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
| Beclomthasone dipropionate's dosage |
|
Definition
|
|
Term
| Beclomthasone dipropionate's instruction |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| Beclomthasone dipropionate's side effects |
|
Definition
| Fungal infections in mouth. Minimal systemic effects |
|
|
Term
| Beclomthasone dipropionate's trade name |
|
Definition
|
|
Term
| Triamcinolone’s side effects? |
|
Definition
| Fungal infection in mouth. Minimal systemic effects |
|
|
Term
| Triamcinolone's classification? |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
|
Definition
| MDI 200 mcg (42 mcg/actuation) |
|
|
Term
| Triamcinolone's instruction? |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| Triamcinolone's trade name |
|
Definition
|
|
Term
| Flunisolide's instructions |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| Flunisolide's side effects |
|
Definition
| Fungal infections in mouth. Minimal systemic effects |
|
|
Term
|
Definition
|
|
Term
| Flunisolide's classification |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
|
Definition
| MDI 500 mcg (250 mcg/actuation) |
|
|
Term
| Fluticasone propionate's instructions? |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| Fluticasone propionate's receptor sites? |
|
Definition
|
|
Term
| Fluticasone propionate's side effects? |
|
Definition
| Increased HR, tremors, nervousness, thrush |
|
|
Term
| Fluticasone propionate's side effects? |
|
Definition
| Fungal infections in the mouth. Minimal systemic effects |
|
|
Term
| Fluticasone propionate's classification? |
|
Definition
| Combo longlasting adrenergic bronchodilator and steroid |
|
|
Term
| Fluticasone propionate's classification? |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
| Fluticasone propionate's dosage? |
|
Definition
MDI/DPI BID (2x/day)
125/25 mcg or 250/25 mcg |
|
|
Term
| Fluticasone propionate's generic names |
|
Definition
|
|
Term
| Fluticasone propionate's trade name? |
|
Definition
|
|
Term
| Budesonide's Receptor sites? |
|
Definition
|
|
Term
| Budesonide's side effects? |
|
Definition
| Increased HR, tremor, nervousness, thrush |
|
|
Term
| Budesonide's side effects? |
|
Definition
| Fungal infections in mouth |
|
|
Term
| What is Budesonide's classification? |
|
Definition
| Combination longacting adrenergic bronchodilator and steroid |
|
|
Term
| What is Budesonide's dosage? |
|
Definition
| MDI 80/4.5 ug and 160/4.5 ug Budesonide and Formoterol 2 puffs BID (MDI = Metered Dose Inhaler) |
|
|
Term
| What is Budesonide's dosage? |
|
Definition
|
|
Term
| What is Budesonide's other generic name? |
|
Definition
| Formoterol fumarate dihydrate |
|
|
Term
| What is Budesonide's trade name? |
|
Definition
|
|
Term
| What is Budesonide's trade name? |
|
Definition
|
|
Term
| What are Fluticasone propionate's instructions? |
|
Definition
| Rinse mouth and/or use spacer |
|
|
Term
| What are Fluticasone propionate's receptor sites? |
|
Definition
| Beta 1, Beta 2 (Hint: Beta 1 (one heart), Beta 2 (two lungs)) Have patient rinse mouth |
|
|
Term
| What are Fluticasone propionate's side effects? |
|
Definition
| Increased HR, tremors, nervousness, thrush |
|
|
Term
| What is Fluticasone propionate's classification? |
|
Definition
| Combination longlasting adrenergic bronchodilator and steroid |
|
|
Term
| What is Fluticasone propionate's classification? |
|
Definition
| Steroidal Antiinflammatory |
|
|
Term
| What is Fluticasone propionate's dosage? |
|
Definition
MDI/DPI BID (2x/day)
2 dosage strengths 125/25 mcg and 250/25 mcg |
|
|
Term
| What is Fluticasone propionate's other generic name? |
|
Definition
|
|
Term
| What is Fluticasone propionate's trade name? |
|
Definition
|
|
Term
| What are Cromolyn sodium's Side effects? |
|
Definition
| Cough and bronchospasm in powder form only |
|
|
Term
| What is Cromolyn sodium's 1st trade name? |
|
Definition
|
|
Term
| What is Cromolyn sodium's 2nd trade name? |
|
Definition
|
|
Term
| What is Cromolyn sodium's classification? |
|
Definition
| NonSteroidal AntiInflammatory (NSAID) |
|
|
Term
| What is Cromolyn sodium's Dosage? |
|
Definition
| 20 mg MDI 1600 mcg (800 mcg/actuation)(MDI = Metered Dose Inhaler) |
|
|
Term
| What is Cromolyn sodium's Instructions? |
|
Definition
| 2 puffs 1015 minutes (not >60) before exercise; cold, dry air or environmental agents for acute |
|
|
Term
| What is Nedocromil sodium's classification? |
|
Definition
| Non Steroidal Anti Inflammatory (NSAID) |
|
|
Term
| What is Nedocromil sodium's dosage? |
|
Definition
| MDI 3.5 mg QID (1.75 mg/actuation)(MDI = Metered Dose Inhaler)(QID = Four times a day) |
|
|
Term
| What is Nedocromil sodium's instruction? |
|
Definition
| Must be taken regularly to achieve benefit |
|
|
Term
| What is Nedocromil sodium's side effect? |
|
Definition
|
|
Term
| What is Nedocromil sodium's trade name? |
|
Definition
|
|
Term
| What are Pentamindine’s side effects? |
|
Definition
|
|
Term
| What is Pentamindine's classification? |
|
Definition
|
|
Term
| What is Pentamindine's dosage? |
|
Definition
600 mg once/day using the Respiguard Nebulizer.
with 6 ml of sterile water. Run at 8 LPM |
|
|
Term
| What is Pentamindine's trade name? |
|
Definition
|
|
Term
| What is Tobramycin's classification? |
|
Definition
|
|
Term
| What is Tobramycin's dosage? |
|
Definition
|
|
Term
| What is Tobramycin's instruction? |
|
Definition
| Do not mix with other meds! |
|
|
Term
| What is Tobramycin's trade name? |
|
Definition
|
|
Term
| inflammation is mediated by |
|
Definition
|
|
Term
| Side Effects Seen With Systemic Administration of Corticosteroids |
|
Definition
| • Hypothalamic–pituitary–adrenal suppression • Immunosuppression • Psychiatric reactions • Cataract formation • Myopathy of skeletal muscle • Osteoporosis • Peptic ulcer • Fluid retention • Hypertension • Increased white blood cell count • Dermatological changes • Growth restriction • Increased glucose levels |
|
|
Term
|
Definition
| Oropharyngeal fungal infections |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Cough, bronchoconstriction |
|
|
Term
| HPA suppression (minimal, dose dependent) |
|
Definition
| Incorrect use of MDI (inadequate dose) |
|
|
Term
eosinophils predominate in _______
neutrophils are mostly seen in ____ |
|
Definition
asthma
COPD
Patient with stable COPD
should not be given systemic corticosteroids |
|
|
Term
| Three subgroups of agents are included in the nonsteroidal antiasthma group: |
|
Definition
cromolyn-like drugs (mast cell stabilizers)
antileukotrienes (anti-LTs)
monoclonal antibodies. |
|
|
Term
| The general indication for clinical use of nonsteroidal antiasthma agents described in this chapter is .... |
|
Definition
| prophylactic management (control) of mild persistent asthma |
|
|
Term
| All of the nonsteroidal antiasthma drugs described in this chapter are _____, not ______, and are used in asthma requiring ________________ |
|
Definition
controllers
relievers
antiinflammatory drug therapy |
|
|
Term
| A sensitized mast cell fails to degranulate after challenge when ________ |
|
Definition
| pretreated with cromolyn sodium |
|
|
Term
|
Definition
| (PCP) Pneumocystis pneumonia |
|
|
Term
| Inhaled tobramycin used for management of ______ infections in patients with cystic fibrosis. |
|
Definition
| Pseudomonas aeruginosa infections in patients with cystic fibrosis. Zanamivir is an inhaled antiviral agent used to treat influenza. |
|
|
Term
| indication for Aerosolized Pentamidine |
|
Definition
| Pentamidine by inhalation is indicated for the prevention of PCP in high-risk HIV–infected patients who have a history of one or more episodes of PCP or a peripheral CD4+ (T4 helper cell) lymphocyte count of 200/mm3 or less. |
|
|
Term
| Indication for Aerosolized Ribavirin |
|
Definition
| in infant respiratory syncytial virus (RSV). |
|
|
Term
| aerosolized pentamidine must be given via |
|
Definition
|
|
Term
| mode of action of pentamidine |
|
Definition
|
|
Term
| Side Effects With Parenteral Pentamidine |
|
Definition
| Pain, swelling, and abscess formation at the site of injection, with intramuscular administration |
|
|
Term
| Side Effects With Aerosol Administration. Side effects with aerosol administration can be differentiated into local airway effects and systemic effects. Local airway effects with aerosol administration have included the following: |
|
Definition
Cough and bronchial irritation in 36% of patients in one study3
Shortness of breath
Bad taste (bitter or burning) of the aerosol impacting in the oropharynx
Bronchospasm and wheezing in 11% of patients3
Spontaneous pneumothoraces13
In addition, the following systemic reactions have occurred with aerosolized pentamidine:
Conjunctivitis
Rash
Neutropenia
Pancreatitis14
Renal insufficiency
Dysglycemia (hypoglycemia and diabetes)
Digital necrosis in both feet15
Appearance of extrapulmonary P. carinii infection |
|
|
Term
| Use of a β-adrenergic bronchodilator before inhaling aerosolized pentamidine can |
|
Definition
| reduce or prevent local airway reaction, including reduction of coughing or wheezing. |
|
|
Term
| Ribavirin (Virazole) is classified as an antiviral drug; it is active against RSV, influenza viruses, and herpes simplex virus. |
|
Definition
|
|
Term
| virostatic - stops it from reproducing |
|
Definition
| virostatic - stops it from reproducing |
|
|
Term
| Infection with RSV in children results in either bronchiolitis or pneumonia. |
|
Definition
| Infection with RSV in children results in either bronchiolitis or pneumonia. |
|
|
Term
| Respiratory syncytial virus (RSV) can cause bronchiolitis and pneumonia. |
|
Definition
| Respiratory syncytial virus (RSV) can cause bronchiolitis and pneumonia. |
|
|
Term
| Ribavirin is given as a 20-mg/ml solution, which is administered by nebulizer (SPAG-2) for 12 to 18 hours per day, for a minimum of 3 days and not more than 7 days. |
|
Definition
| Ribavirin is given as a 20-mg/ml solution, which is administered by nebulizer (SPAG-2) for 12 to 18 hours per day, for a minimum of 3 days and not more than 7 days. |
|
|
Term
|
Definition
|
|
Term
| The use of TOBI is intended to manage chronic infection with P. aeruginosa in cystic fibrosis, as follows: |
|
Definition
| Treat or prevent early colonization with P. aeruginosa |
|
|
Term
|
Definition
for those 6 years or older
300 mg 2 x day
12 hours apart (min. 6 hours apart)
28 days on/28 off |
|
|
Term
| Patients should be instructed not to mix dornase alfa or any other drug with tobramycin in the nebulizer. |
|
Definition
|
|
Term
|
Definition
| Ototoxicity (auditory and vestibular) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Nonsignificant increase in bacterial resistance |
|
|
Term
|
Definition
| Zanamivir (Relenza) is antiviral for treatment of uncomplicated influenza illness (as DPI) in adults and children over 5, during first 2 days of infection. |
|
|
